These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186 [TBL] [Abstract][Full Text] [Related]
24. Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia. Zhang S; Li Y; Li L; Zhang Y; Gao N; Zhang Z; Zhao H J Oral Maxillofac Surg; 2009 May; 67(5):1074-82. PubMed ID: 19375021 [TBL] [Abstract][Full Text] [Related]
25. [Adenoviral p53 gene therapy for human lung cancer]. Fujiwara T; Tanaka N Gan To Kagaku Ryoho; 2003 Apr; 30(4):460-7. PubMed ID: 12722675 [TBL] [Abstract][Full Text] [Related]
26. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938 [TBL] [Abstract][Full Text] [Related]
27. Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients. Griscelli F; Opolon P; Saulnier P; Mami-Chouaib F; Gautier E; Echchakir H; Angevin E; Le Chevalier T; Bataille V; Squiban P; Tursz T; Escudier B Gene Ther; 2003 Mar; 10(5):386-95. PubMed ID: 12601393 [TBL] [Abstract][Full Text] [Related]
28. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317 [TBL] [Abstract][Full Text] [Related]
29. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215 [TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Pataer A; Fanale MA; Roth JA; Swisher SG; Hunt KK Cancer Gene Ther; 2006 Aug; 13(8):806-14. PubMed ID: 16628227 [TBL] [Abstract][Full Text] [Related]
32. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene. Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096 [TBL] [Abstract][Full Text] [Related]
35. p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model. Shirakawa T; Gotoh A; Gardner TA; Kao C; Zhang ZJ; Matsubara S; Wada Y; Hinata N; Fujisawa M; Hanioka K; Matsuo M; Kamidono S J Gene Med; 2000; 2(6):426-32. PubMed ID: 11199263 [TBL] [Abstract][Full Text] [Related]
36. Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin. Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):154-7. PubMed ID: 15314976 [TBL] [Abstract][Full Text] [Related]
37. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Schuler M; Rochlitz C; Horowitz JA; Schlegel J; Perruchoud AP; Kommoss F; Bolliger CT; Kauczor HU; Dalquen P; Fritz MA; Swanson S; Herrmann R; Huber C Hum Gene Ther; 1998 Sep; 9(14):2075-82. PubMed ID: 9759934 [TBL] [Abstract][Full Text] [Related]
38. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054 [TBL] [Abstract][Full Text] [Related]
39. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Buller RE; Runnebaum IB; Karlan BY; Horowitz JA; Shahin M; Buekers T; Petrauskas S; Kreienberg R; Slamon D; Pegram M Cancer Gene Ther; 2002 Jul; 9(7):553-66. PubMed ID: 12082455 [TBL] [Abstract][Full Text] [Related]
40. Clinical significance of p53 in non-small-cell lung cancer. Komiya T; Hirashima T; Kawase I Oncol Rep; 1999; 6(1):19-28. PubMed ID: 9864395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]